Impacts
- 1 - 25 out of 123 results
Search results
-
Access to more effective therapies in Non-Hodgkin Lymphoma
Illidge, T. (Corresponding participant), Radford, J. (Participant) & Honeychurch, J. (Participant)
Impact: Health and wellbeing, Economic
-
Adjuvant therapy in melanoma adopted as standard of care
Lorigan, P. (Participant)
Impact: Health and wellbeing
-
Allowing easier identification of signs of malnutrition using the paperweight armband
Mclaughlin, J. (Corresponding participant)
Impact: Economic, Health and wellbeing
-
A new international lighting standard that meets our biological needs
Lucas, R. (Participant), Brown, T. (Participant), Allen, A. (Participant) & (Participant)
Impact: Technological impacts, Health and wellbeing, Society and culture, Economic
-
A new international measurement standard and guidelines for healthy lighting
Brown, T. (Participant), Lucas, R. (Participant) & Allen, A. (Participant)
Impact: Society and culture, Policy, Economic, Awareness and understanding, Health and wellbeing
-
Antibodies to ACTH and related hormones as diagnostic tools
Anne White (Participant), David Ray (Participant), Steve Crosby (Participant), Sarah Gibson (Participant), Alan Talbot (Participant), Lynn Pritchard (Participant) & Rachel Stovold (Participant)
Impact: Economic impacts, Health impacts, Societal impacts, Technological impacts
-
A phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine (GemX) in muscle-invasive bladder cancer.
Choudhury, A. (Participant)
Impact: Health impacts
-
A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation
Hoskin, P. (Participant), McLean, A. R. (Participant), Adlen, E. K. (Participant), Cardis, E. (Participant), Goodhead, D. T. (Participant), Harms-Ringdahl, M. (Participant), Hendry, J. (Participant), Jeggo, P. A. (Participant), Mackay, D. (Participant), Muirhead, C. R. (Participant), Shepherd, J. (Participant), Shore, R. E. (Participant), Thomas, G. (Participant), Wakeford, R. (Participant) & Godfray, H. C. J. (Participant)
Impact: Health impacts
-
Author of the Irritable Bowel Symptom Severity Scoring System
Peter Whorwell (Participant)
Impact: Health and wellbeing
-
BIOXYDYN: Magnetic Resonance Imaging Biomarkers
(Participant), Jackson, A. (Participant), (Participant) & Naish, J. (Participant)
Impact: Health impacts, Economic impacts
-
BoneFinder
Lindner, C. (Corresponding participant), Cootes, T. (Participant) & Wallis, G. (Collaborator)
Impact: Technological impacts, Health and wellbeing, Economic
-
Capacity building in African research :creation of a multicentre Congenital Heart Disease registry and biorepository in Cape Town (in Partnership with University of Cape Town)
Keavney, B. (Corresponding participant) & Revell, A. (Participant)
Impact: Attitudes and behaviours, Awareness and understanding, Society and culture
-
-
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer (ABC-02). N Engl J Med 362(14): 1273-81
Valle, J. (Corresponding participant)
Impact: Health impacts, Societal impacts
-
Clinical research leading to a new standard of care developed for the management of untreated primary CNS lymphoma
(Participant)
Impact: Health impacts
-
Cochrane Oral Health Group leads the international evidence base for oral health: Antibiotics for the prevention of bacterial endocarditis
Lee Hooper (Participant), Richard Oliver (Participant) & Helen Worthington (Participant)
Impact: Health impacts
-
-
Commercial Development and Patient Benefit of Adoptive Cell Therapy (ACT) for Cancer
Thistlethwaite, F. (Corresponding participant), (Participant), (Participant) & (Participant)
Impact: Technological impacts, Health and wellbeing, Economic, Policy
-
Confirmation that prophylactic irradiation of tracts (PIT) is not justified in routine treatment of malignant pleural mesothelioma (MPM) meaning patients now do not receive unnecessary treatment
Faivre-Finn, C. (Corresponding participant)
Impact: Health and wellbeing
-
Contributed to European Cancer Organisation (ECCO) Essential Requirements for Quality Cancer Care: Prostate cancer guidelines 2020.
Hoskin, P. (Corresponding participant)
Impact: Health and wellbeing
-
Contribution to rapid international consensus guidelines for radiotherapy treatment during the Covid-19 pandemic to reduce risk to patients and staff
Illidge, T. (Corresponding participant)
Impact: Health and wellbeing
-
Creation of an interactive web portal for people with Inflammatory Bowel Disease (IBD) to empower patients and equip them to more actively manage their health - MY IBD portal
Mclaughlin, J. (Corresponding participant) & Lal, S. (Participant)
Impact: Health and wellbeing, Technological
-
Creation of a public resource- a collection of oral histories on the history of the NHS (Voices of our National Health Service)
Snow, S. (Corresponding participant) & Whitecross, A. (Participant)
Impact: Attitudes and behaviours, Awareness and understanding
-
Creation of a research database and management of patients who achieve a clinical complete response (cCR) after neoadjuvant chemo/radiotherapy for rectal cancer through surveillance in order to avoid the risks of surgery
Renehan, A. (Corresponding participant) & (Participant)
Impact: Health and wellbeing
-
Defining immunotherapy in combination with chemotherapy as first-line treatment of patients with advanced biliary tract cancer (durvalumab)
Valle, J. (Corresponding participant) & Mcnamara, M. (Participant)
Impact: Health and wellbeing